Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Peter Lin MD, CCFP
Peter Lin MD, CCFP Associate Editor
Robert Bonakdar MD, FAAFP, FACN
Robert Bonakdar MD, FAAFP, FACN Advisory Board
David Rakel MD, FAAFP
David Rakel MD, FAAFP Editor-in-Chief
See All Experts
story of the week
Published in Primary Care and
2 other channels

Journal Scan / Research · June 05, 2024

Effects of Semaglutide on Chronic Kidney Disease in Patients With Type 2 Diabetes

The New England Journal of Medicine

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Neera Dahl MD, PhD

Peter Lin MD, CCFP

Richard Pratley MD

The New England Journal of Medicine
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
N. Engl. J. Med 2024 May 24;[EPub Ahead of Print], V Perkovic, KR Tuttle, P Rossing, KW Mahaffey, JFE Mann, G Bakris, FMM Baeres, T Idorn, H Bosch-Traberg, NL Lausvig, R Pratley

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated